Su1751 ACHIEVEMENT OF CORTICOSTEROID-FREE CLINICAL, ENDOSCOPIC, AND HISTOLOGIC OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH RISANKIZUMAB: RESULTS FROM THE COMMAND STUDY | Publicación